Kevin Comcowich's most recent trade in Arcadia Biosciences Inc was a trade of 25,455 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 19, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Arcadia Biosciences Inc | Kevin Comcowich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 25,455 | 31,042 | - | - | Stock Option (Right to Buy) | |
Arcadia Biosciences Inc | Kevin Comcowich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 2,186 | 5,587 | - | - | Stock Option (Right to Buy) | |
Arcadia Biosciences Inc | Kevin Comcowich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 55,114 | 136,239 | - | - | Stock Option (right to buy) | |
Arcadia Biosciences Inc | Kevin Comcowich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 25,514 | 81,124 | - | - | Stock Option (right to buy) | |
Arcadia Biosciences Inc | Kevin Comcowich | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2020 | 5,273 | 55,610 | - | - | Stock Option (right to buy) | |
Arcadia Biosciences Inc | Kevin Comcowich | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 21,320 | 50,338 | - | - | Stock Option (right to buy) |